PuSH - Publication Server of Helmholtz Zentrum München

Upadhyay, S. ; Stöger, T. ; Harder, V. ; Thomas, R.F.* ; Schladweiler, M.C.* ; Semmler-Behnke, M. ; Takenaka, S. ; Karg, E.W. ; Reitmeir, P. ; Bader, M.* ; Stampfl, A. ; Kodavanti, U.P.* ; Schulz, S.

Exposure to ultrafine carbon particles at levels below detectable pulmonary inflammation affects cardiovascular performance in spontaneously hypertensive rats.

Part. Fibre Toxicol. 5:19 (2008)
Publ. Version/Full Text Volltext DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Background: Exposure to particulate matter is a risk factor for cardiopulmonary disease but the underlying molecular mechanisms remain poorly understood. In the present study we sought to investigate the cardiopulmonary responses on spontaneously hypertensive rats (SHRs) following inhalation of UfCPs (24 h, 172 mug.m-3), to assess whether compromised animals (SHR) exhibit a different response pattern compared to the previously studied healthy rats (WKY). Methods: Cardiophysiological response in SHRs was analyzed using radiotelemetry. Blood pressure (BP) and its biomarkers plasma renin-angiotensin system were also assessed. Lung and cardiac mRNA expressions for markers of oxidative stress (hemeoxygenase-1), blood coagulation (tissue factor, plasminogen activator inhibitor-1), and endothelial function (endothelin-1, and endothelin receptors A and B) were analyzed following UfCPs exposure in SHRs. UfCPs-mediated inflammatory responses were assessed from broncho-alveolar-lavage fluid (BALF). Results: Increased BP and heart rate (HR) by about 5% with a lag of 1-3 days were detected in UfCPs exposed SHRs. Inflammatory markers of BALF, lung (pulmonary) and blood (systemic) were not affected. However, mRNA expression of hemeoxygenase-1, endothelin-1, endothelin receptors A and B, tissue factor, and plasminogen activator inhibitor showed a significant induction (~2.5-fold; p < 0.05) with endothelin-1 being the maximally induced factor (6-fold; p < 0.05) on the third recovery day in the lungs of UfCPs exposed SHRs; while all of these factors - except hemeoxygenase-1 - were not affected in cardiac tissues. Strikingly, the UfCPs-mediated altered BP is paralleled by the induction of renin-angiotensin system in plasma. Conclusion: Our finding shows that UfCPs exposure at levels which does not induce detectable pulmonary neutrophilic inflammation, triggers distinct effects in the lung and also at the systemic level in compromised SHRs. These effects are characterized by increased activity of plasma renin-angiotensin system and circulating white blood cells together with moderate increases in the BP, HR and decreases in heart rate variability. This systemic effect is associated with pulmonary, but not cardiac, mRNA induction of biomarkers reflective of oxidative stress; activation of vasoconstriction, stimulation of blood coagulation factors, and inhibition of fibrinolysis. Thus, UfCPs may cause cardiovascular and pulmonary impairment, in the absence of detectable pulmonary inflammation, in individuals suffering from preexisting cardiovascular diseases.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
5.110
0.000
31
35
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords PARTICULATE AIR-POLLUTION; CONCENTRATED AMBIENT PARTICLES; INSOLUBLE IRIDIUM PARTICLES; DIESEL EXHAUST INHALATION; RENIN-ANGIOTENSIN SYSTEM; HEART-RATE-VARIABILITY; FINE PARTICULATE; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; MATTER EXPOSURE
Language english
Publication Year 2008
HGF-reported in Year 0
ISSN (print) / ISBN 1743-8977
e-ISSN 1743-8977
Quellenangaben Volume: 5, Issue: , Pages: , Article Number: 19 Supplement: ,
Publisher BioMed Central
Publishing Place London
Reviewing status Peer reviewed
POF-Topic(s) 30202 - Environmental Health
30203 - Molecular Targets and Therapies
Research field(s) Genetics and Epidemiology
Enabling and Novel Technologies
PSP Element(s) G-505300-002
G-505200-003
G-505000-005
PubMed ID 19055790
Scopus ID 58149328691
Erfassungsdatum 2008-12-31